Yuichiro Minami

Yuichiro Minami

Auto-generated profile, based on publicly available information

Yuichiro Minami

Department of Cardiology, Tokyo Women’s Medical University, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in JACC
Verified
Journal Article
Closed access
YMYuichiro Minami
Yuichiro Minami
KKKatsuya Kajimoto
Katsuya Kajimoto
YTYutaka Terajima
Yutaka Terajima
BYBun Yashiro
Bun Yashiro
DODai Okayama
Dai Okayama
NHNobuhisa Hagiwara
Nobuhisa Hagiwara

1 April 2016 in Stroke
Verified
Journal Article
Closed access
SHShintaro Haruki
Shintaro Haruki
YMYuichiro Minami
Yuichiro Minami
NHNobuhisa Hagiwara
Nobuhisa Hagiwara
Background and Purpose—: Stroke and systemic embolic events are known to occur as complications of hypertrophic cardiomyopathy (HCM), and these complications are more common in patients with accompanying atrial fibrillation (AF). The diagnosis of AF is sometimes difficult, however, and it is possible that subclinical asymptomatic paroxysmal episodes or a first episode of AF in patients without previously documented AF may lead to embolic events. We investigated the prevalence of embolic events in patients with HCM and evaluated risk factors for these events in patients without documented AF. Methods—: This study enrolled 593 patients with clinically diagnosed HCM (age at diagnosis, 51.0±15.6 years) from 1980 to 2010. Results—: During a mean follow-up of 10.7±7.5 years, 68 (11.5%) experienced stroke and embolic events. AF had been documented before the event in 29 (42.6%) of them. AF was documented for the first time at the time of the event in 5 (7.4%) and after the event in 10 (14.7%). Among the 431 patients without previously documented AF (39 with events and 392 without events), older age at diagnosis and left atrial dimension ≥48 mm were identified as the independent determinants of the embolic event after adjusting for sex and classic prognostic markers related to HCM. Conclusions—: The incidence of stroke and embolic events was about 1.0% per year in the HCM cohort. AF had not been previously documented before the event in more than half of patients with events. Older age and enlarged left atrial dimension are possible risk factors for embolic events in patients with HCM without documented AF.

1 October 2018 in Journal of Cardiology
Verified
Journal Article
Closed access
CSChihiro Saito
Chihiro Saito
YMYuichiro Minami
Yuichiro Minami
KAKotaro Arai
Kotaro Arai
SHShintaro Haruki
Shintaro Haruki
YYYoshimi Yagishita
Yoshimi Yagishita
NHNobuhisa Hagiwara
Nobuhisa Hagiwara

1 December 2014 in Journal of Cardiology
Verified
Journal Article
Closed access
YMYuichiro Minami
Yuichiro Minami
SHShintaro Haruki
Shintaro Haruki
NHNobuhisa Hagiwara
Nobuhisa Hagiwara

29 July 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
KMKeiko Mizobuchi
Keiko Mizobuchi
KJKentaro Jujo
Kentaro Jujo
YMYuichiro Minami
Yuichiro Minami
IIIssei Ishida
Issei Ishida
MNMasashi Nakao
Masashi Nakao
NHNobuhisa Hagiwara
Nobuhisa Hagiwara
Introduction: Peripheral artery disease (PAD) occurs at an advanced stage of atherosclerosis and its comorbidities are associated with poor prognoses. Malnutrition is related to the severity of atherosclerosis in patients with cardiovascular disease and it predicts mortality. The Controlling Nutritional Status (CONUT) score is calculated from serum albumin concentration, peripheral lymphocyte count and total cholesterol concentration, and it robustly represents the nutritional status of hospitalized patients. This study aimed to determine the prognostic value of the CONUT score in patients with peripheral artery disease (PAD) who were undergoing endovascular therapy (EVT). METHODS and RESULTS: This study included 628 PAD patients who underwent EVT between 2013 and 2017 and were assigned to low (CONUT score 0: n = 81), mild (CONUT score 1–2: n = 250), moderate (CONUT score 3–4: n = 169), and high (CONUT score ≥ 5: n = 128) risk groups. The study’s primary endpoint was any death. Patients in the groups with higher CONUT scores were more likely to have chronic kidney disease (p < 0.001), impaired left ventricular ejection fractions (p < 0.001), and critical limb ischemia (p < 0.001) on admission. During follow-up, 95 patients (15%) died. Kaplan–Meier analyses revealed that the patients with higher CONUT scores had lower survival rates (p < 0.001; log-rank trend test). Multivariate Cox regression analyses showed that following adjustments for the confounding factors, a higher CONUT score was significantly associated with any death (hazard ratio, 1.15; 95% confidence interval, 1.03–1.30). CONCLUSION: The simple index CONUT score at the time of EVT may predict long-term mortality in PAD patients.

1 September 2015 in Journal of Cardiology
Verified
Journal Article
Closed access
DODai Okayama
Dai Okayama
YMYuichiro Minami
Yuichiro Minami
SKShohei Kataoka
Shohei Kataoka
TSTsuyoshi Shiga
Tsuyoshi Shiga
NHNobuhisa Hagiwara
Nobuhisa Hagiwara